Home »
Academic Articles & Research Papers
Showing 13 of 33 academic articles
Sophia Daum, Lilith Decristoforo, Mira Mousa, Stefan Salcher et al. • Molecular Cancer
(2025)
Abstract The dynamic interactions between tumor endothelial cells (TECs) and the immune microenvironment play a critical role in the progression of non-small cell lung cancer (NSCLC). In general, endothelial cells exhibit diverse immunomodu...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12943-024-02221-6
Ziqiang Wang, Jing Zhang, Huili Chen, Xinyu Zhang et al. • Frontiers in Immunology
(2025)
BackgroundM2-like tumor-associated macrophages (TAMs) promote an immunosuppressive microenvironment and contribute to tumor progression and metastasis. However, their molecular characterization and prognostic value have not been fully explo...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1650726
Chun-Hua Wang, Lu-Kai Wang, Fu-Ming Tsai • Current Issues in Molecular Biology
(2025)
Tazarotene, a retinoid derivative, is widely used in treating skin conditions such as psoriasis and acne. Recent studies have demonstrated its potential as a promising therapeutic agent for treating melanoma in situ. Its primary mechanism o...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cimb47040237
Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro et al. • BMC Cancer
(2022)
Abstract Background Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor b...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12885-022-09689-9
Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena et al. • Frontiers in Immunology
(2025)
Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic malignancies, achieving remarkable clinical success with FDA-approved therapies targeting CD19 and BCMA. However, the extension of these successe...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2024.1489827
Zhou Z, Hong Y, You J, Que K et al. • Cell biology and toxicology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1007/s10565-026-10324-7
PMC: PMC13736382
Zhen Wang, Honglei Guo, Yanqi Song, Aidi Wang et al. • Frontiers in Immunology
(2025)
Lung cancer is the most common malignant tumor in the world. Presently, there are still problems, including a high recurrence rate, resistance, and serious toxic side effects, even if conventional treatments like chemotherapy, radiotherapy,...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1597686
Zhongru Fan, Dongyu Han, Xin Fan, Lin Zhao • Frontiers in Immunology
(2023)
BackgroundOvarian cancer (OC) is one of the malignant tumors that poses a serious threat to women’s health. Natural killer (NK) cells are an integral part of the immune system and have the ability to kill tumor cells directly or participate...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2023.1308143
Ching-Yun Wang, Shiuan-Chen Lin, Kao-Jung Chang, Han-Ping Cheong et al. • Heliyon
(2024)
Acute myeloid leukemia (AML) establishes an immunosuppressive microenvironment that favors leukemic proliferation. The immune-suppressive cytokines altered antigen processing, and presentation collectively assist AML cells in escaping cytot...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.heliyon.2024.e39731
Qingwei Wu, Zhifa Ge, Chengyu Lv, Qifeng He • Frontiers in Immunology
(2025)
Autoimmune hepatitis (AIH) is a progressive liver inflammatory disease mediated by an autoimmune response, with an increasing incidence rate. In severe cases, AIH will rapidly progress to liver cirrhosis and liver failure and even lead to d...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1584001
Gu Y, Xu Z, Zhao J, Li H et al. • Frontiers in oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fonc.2026.1954751
PMC: PMC13732472
Fangmin Zhong, Fangyi Yao, Zihao Wang, Bo Huang et al. • npj Precision Oncology
(2025)
Abstract Acute myeloid leukemia (AML) remains challenging due to molecular heterogeneity and limited prognostic models integrating tumor microenvironment dynamics. While thrombocytopenia correlates with poor outcomes, the roles of platelet-...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41698-025-01137-8
Yiming Mao, Ting Li, Wenqiang Lu, Chunhong Li et al. • Discover Oncology
(2025)
Abstract Glioblastoma (GBM) is an extremely aggressive and diverse type of brain tumor that is associated with a poor prognosis. Immunogenic cell death (ICD) is a particular form of cellular demise that is closely linked to antineoplastic i...
DOAJ
Open Access (DOAJ)
DOI: 10.1007/s12672-025-03557-1